



Markets
/
Stocks
/
nasdaq-mrk
/

Merck & Co Inc

MRK

View Detailed Chart

85.090USD

+0.380+0.45%

Close 04/30, 16:00（ET）Quotes delayed by 15 min

215.08BMarket Cap

12.57P/E TTM



Merck & Co Inc

85.090

+0.380+0.45%

Company

Intraday

30m

Today

+0.45%

5 Days

+8.06%

1 Month

-4.64%

6 Months

-18.83%

Year to Date

-14.47%

1 Year

-34.15%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 28 analysts

BUY

Current Rating

105.890

Target Price

25.00%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

162

Total

Median

Average

Company name

Ratings

Analysts

Merck & Co Inc

MRK

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(2)

Buy(3)

Indicators

Sell(1)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

1.974

Neutral

RSI(14)

54.249

Neutral

STOCH(KDJ)(9,3,3)

88.545

Overbought

ATR(14)

3.010

Low Volatility

CCI(14)

208.427

Overbought

Williams %R

10.041

Overbought

TRIX(12,20)

-0.485

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

81.844

Buy

MA10

79.889

Buy

MA20

80.921

Buy

MA50

87.316

Sell

MA100

92.303

Sell

MA200

102.030

Sell

News

Merck & Co Inc reports results for the quarter ended December 31 - Earnings Summary

Merck & Co Inc MRK.N reported quarterly adjusted earnings of $1.72 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 3 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $1.62 per share. Wall ...

ReutersTue, Feb 4

U.S. STOCKS ON THE MOVE-Merck & Co, Sirius XM Holdings, Palantir Technologies

Eikon search string for individual stock moves: The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures were slightly lower on Tuesday as investors stayed away from risky assets after China deployed retaliatory tariffs...

ReutersTue, Feb 4

Company

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It sells its products to veterinarians, distributors, animal producers, farmers and pet owners.

Company codeMRK

CompanyMerck & Co Inc

CEOMr. Robert M. (Rob) Davis

Websitehttps://www.merck.com/